Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Retatrutide for Sale > Retatrutide 99% Purity Research Peptide Powder with Batch COA CAS 2381089-83-2
Retatrutide 99% Purity Research Peptide Powder with Batch COA CAS 2381089-83-2 buy - large image1
Retatrutide 99% Purity Research Peptide Powder with Batch COA CAS 2381089-83-2 buy - image1
Retatrutide 99% Purity Research Peptide Powder with Batch COA CAS 2381089-83-2 buy - image2
Retatrutide 99% Purity Research Peptide Powder with Batch COA CAS 2381089-83-2 buy - image3
Retatrutide 99% Purity Research Peptide Powder with Batch COA CAS 2381089-83-2 buy - image4
Retatrutide 99% Purity Research Peptide Powder with Batch COA CAS 2381089-83-2 buy - image5
Retatrutide 99% Purity Research Peptide Powder with Batch COA CAS 2381089-83-2 buy - image6

Retatrutide 99% Purity Research Peptide Powder with Batch COA CAS 2381089-83-2

6735 Inquiries

Unit Price:

$90/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Ningbo

Brand:

Ascent

Packaging:

5/10/15/20/30/60mg 10vials/box

Price valid (until):

2026-09-25

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Semaglutide,Tirzepatide,Cagrilintide,Cosmetic Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    RETATRUTIDE — QUICK SOURCING INFORMATION

    Item

    Details

    Product

    Retatrutide

    CAS No.

    2381089-83-2

    Purity

    ≥99% by HPLC*

    Appearance

    White to off-white powder

    Specification

    Flexible mg-g scale

    MOQ

    Flexible

    Packaging

    Multiple packaging options available

    COA

    Available on request

    HPLC

    Available on request

    MS

    Available on request

    Lead Time

    Please confirm current availability


    * Final batch specification is subject to the corresponding batch COA.

    Need the current COA, HPLC/MS data or latest price? Please send your required quantity and destination through the ECHEMI inquiry form in the end.

    Shop Retatrutide Powder High Purity Research Peptide CAS 2381089-83-2 COA Available-Detailed Image 1 Shop Retatrutide Powder High Purity Research Peptide CAS 2381089-83-2 COA Available-Detailed Image 2 Shop Retatrutide Powder High Purity Research Peptide CAS 2381089-83-2 COA Available-Detailed Image 3 Shop Retatrutide Powder High Purity Research Peptide CAS 2381089-83-2 COA Available-Detailed Image 4 Shop Retatrutide Powder High Purity Research Peptide CAS 2381089-83-2 COA Available-Detailed Image 5 Shop Retatrutide Powder High Purity Research Peptide CAS 2381089-83-2 COA Available-Detailed Image 6 Shop Retatrutide Powder High Purity Research Peptide CAS 2381089-83-2 COA Available-Detailed Image 7 Shop Retatrutide Powder High Purity Research Peptide CAS 2381089-83-2 COA Available-Detailed Image 8

    Product Overview

    Retatrutide is a synthetic peptide designed for GIP, GLP-1 and glucagon receptor-related research. As a triple receptor agonist research peptide, Retatrutide has attracted significant attention in metabolic pathway, receptor signaling and peptide drug discovery studies. ASCENT supplies Retatrutide for qualified customers requiring reliable batch documentation, flexible quantities and responsive international supply support. We focus on the information that matters most: identity, purity, batch consistency, analytical documentation, packaging and delivery.

    Why Choose ASCENT Retatrutide

    High Purity: Typical supply specification of ≥99% purity by HPLC, with batch-specific analytical documentation available.

    Batch Documentation: Supporting documentation may include COA, HPLC chromatogram, MS data, batch information and product specification. Availability can be confirmed before ordering.

    Flexible Order Quantities: Suitable for evaluation quantities, regular purchasing and bulk requirements. Quantity and packaging can be discussed according to the project.

    Packaging Options: Small-quantity peptide packaging, bulk packaging, multiple-unit packaging and customized outer packaging can be discussed according to order requirements.

    International Supply Support: ASCENT supports international inquiries with responsive quotation, document preparation and shipment coordination.


    Quality Control & Documentation

    For peptide sourcing, purity alone is not enough. HPLC is used to evaluate chromatographic purity, while mass spectrometry supports molecular identity verification. A batch-specific COA links the analytical results to the corresponding batch. Customers may request available analytical documents before order confirmation.

    HPLC: Used to evaluate chromatographic purity.

    MS: Used to support molecular identity verification.

    COA: Provides batch-specific product information and analytical results.

    Batch-specific COA, HPLC chromatogram and MS data can be provided for customer review. Please send your product quantity and requirement through the ECHEMI inquiry form for current batch information.

     

    Flexible Order & Packaging Solutions

    Evaluation Quantity: Suitable for initial supplier or product evaluation.

    Regular Purchasing: Suitable for repeat purchasing and stable documentation requirements.

    Bulk Requirement: Pricing, packaging and delivery schedule can be discussed according to the required quantity.

    Packaging: Sealed peptide packaging and customized packaging options are available according to quantity and project requirements.


    Get an Accurate Quotation

    Please use the ECHEMI inquiry form below and provide: Product Name / CAS No. | Required Quantity | Destination Country | Purity / Specification Requirement | Packaging Requirement | Preferred Shipment Term (if applicable).

    For COA, HPLC/MS data or current batch information, mention your request in the Message field. Our team will respond with current availability, quotation, packaging options and applicable analytical documentation.

     

     

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Other Chemical Drugs

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Semaglutide,Tirzepatide,Cagrilintide,Cosmetic Peptides

    Location:

    ROOM 203, 2ND FLOOR, BUILDING 2, NO. 265 CHENGRUI STREET, XIASHA STREET, QIANTANG DISTRICT, HANGZHOU CITY, ZHEJIANG PROVINCE,CHINA 310020

    Payment Terms:

    TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2022

    Founded in 2022 and based in Qiantang District, Hangzhou, Zhejiang Province, China, ASCENT is a global supplier of specialty ingredients serving the pharmaceutical, biotechnology, food, nutrition, cosmetic, and personal care industries.

    Our portfolio includes active pharmaceutical ingredients (APIs), peptides, pharmaceutical intermediates, food additives, and cosmetic ingredients. We work with pharmaceutical and biotechnology companies, research institutions, food and nutrition businesses, cosmetic brands, manufacturers, formulation developers, distributors, and professional buyers worldwide.

    At ASCENT, we believe that better ingredients provide the foundation for better products. By combining reliable products, professional support, and efficient supply solutions, we help our customers simplify international sourcing, advance product development, and bring new ideas closer to market.

  • Inquiry History
    6735 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.